Search by Drug Name or NDC

    NDC 69097-0439-35 Palonosetron hydrochloride 0.25 mg/5mL Details

    Palonosetron hydrochloride 0.25 mg/5mL

    Palonosetron hydrochloride is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cipla USA Inc.. The primary component is PALONOSETRON HYDROCHLORIDE.

    Product Information

    NDC 69097-0439
    Product ID 69097-439_b4ddbb13-5b11-40b1-b126-dc2d1b44c9dd
    Associated GPIs 50250070102020
    GCN Sequence Number 052943
    GCN Sequence Number Description palonosetron HCl VIAL 0.25MG/5ML INTRAVEN
    HIC3 H6J
    HIC3 Description ANTIEMETIC/ANTIVERTIGO AGENTS
    GCN 20228
    HICL Sequence Number 025512
    HICL Sequence Number Description PALONOSETRON HCL
    Brand/Generic Generic
    Proprietary Name Palonosetron hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Palonsetron hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 0.25
    Active Ingredient Units mg/5mL
    Substance Name PALONOSETRON HYDROCHLORIDE
    Labeler Name Cipla USA Inc.
    Pharmaceutical Class Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA206396
    Listing Certified Through 2024-12-31

    Package

    NDC 69097-0439-35 (69097043935)

    NDC Package Code 69097-439-35
    Billing NDC 69097043935
    Package 1 VIAL, SINGLE-USE in 1 CARTON (69097-439-35) / 5 mL in 1 VIAL, SINGLE-USE
    Marketing Start Date 2021-10-10
    NDC Exclude Flag N
    Pricing Information N/A